Protein ENGineering (PENG)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-PS-26-129
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AC12
Additional Details
The Defense Advanced Research Projects Agency (DARPA), operating under the Department of Defense, has released a solicitation (Procurement Identifier: DARPA-PS-26-129) for the Protein ENGineering (PENG) program. This initiative seeks innovative proposals aimed at revolutionizing the field of proteome engineering by developing a multifunctional, target-agnostic platform for precise, programmable editing of endogenous proteins. The overarching objective is to transition protein engineering from a fragmented set of bespoke tools into a universal, software-defined discipline, thereby enabling broad and flexible manipulation of protein function within complex biological systems.
The scope of the PENG program encompasses the creation of an integrated platform that combines modular targeting strategies, generalizable effector chemistries, and multiplexed control systems. Rather than focusing on isolated, target-specific solutions, DARPA is seeking approaches that integrate novel splicing, ligation, and co-translational techniques. These methods should be capable of directly recognizing, modifying, and rewriting endogenous proteins within intricate biological architectures. The program encourages performers to explore multiple technical pathways, advancing their solutions from foundational validation stages through to robust demonstrations of efficacy.
A critical requirement of the program is the validation of the integrated platform in high-fidelity cellular models, such as organoids, to provide a comprehensive proof-of-concept at the tissue level. Expected deliverables include a fully integrated, modular platform capable of precise and programmable protein editing, supported by demonstrations of its effectiveness in relevant biological contexts.
This opportunity is classified under NAICS Code 541714 (Research and Development in Biotechnology, except Nanobiotechnology) and Product Service Code AC12. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), a federal office within the Department of Defense. Interested parties may direct inquiries to the BAA Coordinator at [email protected].
The solicitation is currently active, with a post date of August 21, 2026, and responses due by October 19, 2026. All relevant attachments and further details can be accessed via the official SAM.gov opportunity listing (Opportunity ID: 8d7bb66b691a4def9e7efe4d4345bb7a).
Contractors with expertise in biotechnology research and development, particularly those with capabilities in protein engineering, modular platform development, and advanced cellular model validation, are encouraged to review the solicitation in detail to assess alignment with their technical strengths and strategic objectives. No specific set-aside requirements or special considerations are noted in the provided information.
Documents13